AMANDA HUMBERS: Open Payments
NPI 1720421514 · FARMINGTON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,285 in 125 payments from 30 companies in 2025. Trend: 2023 $4,683 · 2024 $3,769 · 2025 $2,285
Food & beverage: $2,285
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 13 | $231 |
| ABBVIE INC. | 15 | $212 |
| ARGENX US, INC. | 8 | $168 |
| Alexion Pharmaceuticals, Inc. | 6 | $162 |
| EMD Serono, Inc. | 8 | $159 |
| PFIZER INC. | 22 | $151 |
| JAZZ PHARMACEUTICALS INC. | 5 | $115 |
| Neurocrine BioSciences, Inc. | 4 | $106 |
| Lilly USA, LLC | 5 | $90 |
| TG Therapeutics, Inc. | 3 | $88 |
Products named: VYVGART HYTRULO, ULTOMIRIS, NURTEC ODT, QULIPTA, EPIDIOLEX, INGREZZA, Rystiggo, KISUNLA.
Industry payments across MO — which companies pay providers there.
